The short version of pentadecapeptide fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-03-30 and is reviewed periodically as new material appears.
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
Most early work on this peptide originated in the 1990s from a research group in Zagreb, Croatia, relying on animal models and cell cultures. Reported observations included effects on gastrointestinal lesion healing, tendon fibroblast migration, and blood vessel formation under controlled laboratory conditions. These findings come predominantly from rodent studies and in vitro assays rather than from human trials. Controlled human data remain limited, and the degree to which animal results translate to human physiology is an open question rather than a settled fact.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
BPC-157 is normally distributed as a lyophilised powder that ranges from white to off-white in appearance. The peptide dissolves readily in water, normal saline, and common aqueous buffers, and it is poorly soluble in nonpolar solvents such as hexane or vegetable oils. Lyophilised vials take up moisture if left open, which changes the mass of powder in the container and complicates any later weighing. Because the material is handled in small quantities, static and adhesion to glass or plastic can also cause noticeable losses during transfer.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C62H98N16O22 | computed for the free peptide |
| Molecular weight | about 1419 Da | monoisotopic mass near 1418.7 |
| Amino acid count | 15 | single chain, no disulfide bonds |
| Solubility | freely soluble in water | also dissolves in saline and phosphate buffer |
| Common synonyms | pentadecapeptide BPC, BPC 157 | fragment notation varies by source |
Proposed mechanisms in the literature involve the nitric oxide system, vascular endothelial growth factor signaling, and epidermal growth factor receptor pathways. Some studies report changes in blood vessel formation or in inflammatory mediators, while others describe interactions with nervous tissue. Much of this evidence rests on molecular markers in cultured cells or animal models. Whether the same pathways operate the same way in humans has not been established. Authors therefore tend to describe mechanisms as hypothetical rather than settled.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
However, Compulsion also said that with this expanded title, the price of the game will be increased from $30 to $60, with those that backed the Kickstarter or purchased the early access versions getting the full game and some of the downloadable content that is planned for free. Compulsion plans to offer a season pass for additional content that will be developed after release, enabled by Gearbox's backing. Compulsion's community manager Nadia Hadjas said that neither Microsoft nor Gearbox provided oversight on the game, allowing Compulsion to develop the title based on their own goals and the community's feedback. In May 2018, the Australian Classification Board had refused classification for We Happy Few, identifying that gameplay mechanics around the use of Joy pills was problematic, which would prevent the game from being sold in Australia. The Board stated in their refusal that because "the game's drug-use mechanic making game progression less difficult constitutes an incentive or reward for drug-use and therefore, the game exceeds the R18+ classification that states, 'drug use related to incentives and rewards is not permitted'". Compulsion Games said that it was working with the Board to challenge their ruling and make the game appropriate to be rated, stating that they believe that the use of Joy was part of the game's themes, "It's a society that is forcing its citizens to take Joy, and the whole point of the game is to reject this programming and fight back", and compared this theme to that of Aldous Huxley's Brave New World and Terry Gilliam's Brazil.
The substrates of this enzyme are mevalonic acid, coenzyme A, and oxidised nicotinamide adenine dinucleotide (NAD+). Its products are 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA), reduced NADH, and two protons. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is (R)-mevalonate:NAD+ oxidoreductase (CoA-acylating). Other names in common use include beta-hydroxy-beta-methylglutaryl coenzyme A reductase, beta-hydroxy-beta-methylglutaryl CoA-reductase, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and hydroxymethylglutaryl coenzyme A reductase.
the equation indicates that the decay constant λ has units of t−1, and can thus also be represented as 1/τ, where τ is a characteristic time of the process called the time constant. In a radioactive decay process, this time constant is also the mean lifetime for decaying atoms. Each atom "lives" for a finite amount of time before it decays, and it may be shown that this mean lifetime is the arithmetic mean of all the atoms' lifetimes, and that it is τ, which again is related to the decay constant as follows:
Drug delivery to the brain is the process of passing therapeutically active molecules across the blood–brain barrier into the brain. This is a complex process that must take into account the complex anatomy of the brain as well as the restrictions imposed by the special junctions of the blood–brain barrier.
According to the Pew Research Center, 99.8% of Somalia's population is Muslim. The majority belong to the Sunni branch of Islam and the Shafi'i school of Islamic jurisprudence. Sufism, the mystical dimension of Islam, is well-established, with many congregations of various Sufi orders. It is the state religion. Christianity has around 1,000 adherents, less than 0.1% of the 2010 population. There were no Christians during early colonisation, although 100–200 followers came from the Catholic missions in British Somaliland, with no Catholic missions in Italian Somaliland. According to the Pew Research Center, less than 0.1% of Somalia's population, mainly Bantus, were adherents of folk religions.
Sources: en.wikipedia.org
== Use and effects == Ibotenic acid acts as a prodrug to muscimol, with approximately 10-20% being converted to muscimol via decarboxylation in the gastrointestinal tract following oral ingestion. It also has substantial pharmacological activity on its own, producing excitatory effects such as agitation. Some preparation methods of Amanita muscaria, such as drying or heating, decarboxylate a portion of ibotenic acid into muscimol prior to consumption. Substantial amounts of ibotenic acid and muscimol are excreted rapidly in urine following consumption, underpinning historical accounts of Siberian urine recycling practices involving Amanita muscaria mushrooms. Threshold psychoactive effects of muscimol occur at a dose of 6 mg, whereas threshold effects of ibotenic acid occur with doses 5-10 times higher, or about 30-60 mg. The onset of ibotenic acid is slow, with full effects developing after 2-3 hours, while the duration is 6-8 hours.
Later in 2020, the leaks gained more attention and grew in size, culminating into the release of Wii and Nintendo 64 source code, and the so-called "Gigaleak", a massive release containing multiple N64 games' source code and SNES Prototypes. On August 7, 2020, 20 GB of Intellectual property of Intel, including source code (in SystemVerilog and otherwise) of their system on chips leaked (with preserving git structure). That included Intel ME, Intel Microcode and software simulators of their hardware. Their various BIOS source code was also leaked. The SpaceX cameras firmware that Intel worked on also leaked. The data is being distributed through a torrent. On September 23, 2020, Windows XP SP1 and Windows Server 2003 complete source code depots were leaked. The archives included all the source code from the time it was used at Microsoft, including documentation and build tools. The leak was first dismissed as illegitimate, but it was soon clear that it was legitimate, the source code contained Windows XP specific code and resources, later one user managed to compile the OS and pack it into an ISO image. On January 4, 2021, Nissan North America source code was leaked online due to misconfiguration of a company Git server, which was left exposed online with a default username and password of admin/admin. Software engineer maia arson crimew learned of the leak and analyzed the data, which they shared with ZDNet.
Carbon-14 (also called radiocarbon) occurs in trace amounts and has a half-life of 5730 years. The primary source of 14C on Earth is the reaction of 14N with thermal neutrons from cosmic radiation spallation reactions in the upper atmosphere; this mixes throughout the atmosphere, and biological processes such as photosynthesis incorporate the 14C into living organisms. Since organisms stop absorbing 14C upon dying, measurement of the amount of 14C in a sample may be used to estimate its age. This technique, called radiocarbon dating, is one of the principal methods of radiometric dating in archaeology.
As researchers, usually with little time, usually conduct these tasks themselves and manually and the, largely cosmetic, unstandardized changes are required before, not after, the paper is accepted for publication, the study proposes journals start allowing "free-format submissions". A study (25 May) highlights a list of problematic persuasive methods in academic articles, such as exaggerating the importance of the work or insufficient contextualization by "Not citing previous work that decreases the perceived novelty of the current work".
Sources: en.wikipedia.org
The sequence corresponds to a fragment of a protein found in human gastric juice, so related sequences are natural. The isolated fifteen-amino-acid peptide supplied for research is produced synthetically. Whether the free fragment circulates naturally in humans has not been settled.
In most jurisdictions it is not an approved medicine and is handled as a research material. Import and sale rules differ by country, and some regulators have placed it in categories that restrict human use. Status can change, so current local rules apply.
Rodent models dominate, particularly rats with induced gastric lesions, tendon injury, or vascular disruption. These designs allow controlled comparison but differ anatomically and metabolically from humans. Results from such models are commonly cited as preliminary.
Lyophilised peptide powders are generally kept frozen or refrigerated, dry, and protected from light. Sealed vials limit moisture uptake and slow hydrolysis. Such guidance comes from general peptide chemistry rather than from stability studies specific to every product.